Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

NCT: NCT05868148 · ACTIVE_NOT_RECRUITING

NCT IDNCT05868148
StatusACTIVE_NOT_RECRUITING
Start Date2023-10-20
Completion2035-12
SponsorStryker Trauma and Extremities (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in adult patients who have a functional deltoid muscle and massive and non-repairable rotator cuff tear. The main questions it aims to answer are: * What is the average improvement in patient-reported shoulder function after 2 years when compared to before the surgery, and * What is the rate of surgical revisions needed over a 10 year period Patients will be asked to will be asked to regularly attend their check-up visits with their surgeon (including having x-rays or CT images taken to check their shoulder and implant), to complete questionnaires to report how their shoulder is doing, and to tell their surgeon when they notice any changes.

Frequently Asked Questions

What is Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study?

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is a clinical trial registered under NCT05868148. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05868148?

The current status of NCT05868148 (Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study) is: ACTIVE_NOT_RECRUITING.

When did Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study start?

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study started on 2023-10-20.

Related Devices

K241491Blueprint Patient-Specific Instrumentation; Shoulder iD Primary Reversed GlenoidStryker Corporation (Tornier, S.A.S.) K211359Tornier Perform™ Patient-Matched Primary Reversed Glenoid and BLUEPRINT™ Patient Specific InstrumentationTornier, Inc. K260102Tornier Perform Reversed Glenoid and Tornier Perform Reversed Augmented Glenoid Shoulder SystemStryker Corporation (Tornier, Inc.)

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑